1. Discrete choice experiments in health economics: a review of the literature;Clark;Pharmacoeconomics,2014
2. Discrete choice experiments in health economics: a review of the literature;de Bekker-Grob;Health Econ,2012
3. Using discrete choice experiments to value health care programmes: current practice and future research reflections;Ryan;Appl Health Econ Health Policy,2003
4. Food and Drug Administration. Patient preference information—voluntary submission, review in premarket approval applications, humanitarian device exemption applications, and de novo requests, and inclusion in decision summaries and device labeling: guidance for Industry, Food and Drug Administration staff, and other stakeholders. Available from: https://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM446680.Pdf. [Accessed January 12, 2018].
5. Institute for Quality and Efficiency in Health Care. General methods (benefit assessment) version 5.0. Available from: https://www.iqwig.de/en/methods/methods-paper.3020.html. [Accessed January 12, 2018].